About Servier
Servier is a privately held, global research-based pharmaceutical company that places innovative therapies for patients at the center of all its activities. With 22,500 employees, France's second-largest pharmaceutical company generated sales of around 4.7 billion euros in 150 countries in 2020. Every day, it provides care to 100 million patients worldwide. Servier invests more than 20 percent of its pharmaceutical sales revenue annually in research and development of new medicines. As a leader in the field of cardiology, Servier also aims to establish itself as a renowned and innovative company in the field of oncology/hematology. The German subsidiary of the long-established French company, headquartered in Suresnes near Paris, was founded in Munich in 1996. The support of scientific research and sponsorship awards as well as a high level of social commitment are part of Servier's basic ethical stance.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
- Focus : Manufacturer
- Industry : Pharma
